Member Info for Early_Bird

https://twitter.com/power_thompson/status/1247077546082078721

Drilling soon to be kicking off (covid19 permitting) hopefully update imminently.
Great time to be buying here

Funding wont be a problem. Do not underestimate Matt Bull, the guy is great at picking elephants and has big support over in Aus. He was instrumental in taking Volt from $1m to $180m cap after joining their as a director, think he may have been the one that even sourced their asset.

8% holder here, so him being on the board protects our shareholder interests.

Upgrade DFS I think will catch the market napping here. Added more here today

yes, I always rather turn up to the party early, get a nice position and wait for the noise surrounding the big catalyst to come.
Here it seems to me an obvious value play, with £12-14m in liquid assets that more than justifies the current MCap alone. 100% XIVI in for free, a company with a P3 approved drug that's looking for commercialisation this year (pending FDA) in a huge market ($300b in Russia alone).

On AIM you have Pharma companies at just phase 1/2 trials valued more than this and with nothing like the cash/liquid assets. P3/commercialisation stage is a huge value step change higher which is where OVB's drug is and its valued at an EV of 0..... crazy! I mean they paid $11m for it for starters

Looks like I may have jumped the gun thinking FDA would be 1-2months as the 160 working days since filing doesn't include for to/from pauses. This is looking like H2 is more likely. The EU/US trials though last guidance was mid year for that. (this is a huge $2.25b market).

Some odd games been played here by MMs, assume they have just lost their supply of shares from the resident seller (good sign!).

100% agree, id say the upside is *a lot* higher than double this SP if FDA is approved. When Pharma goes on a run it can really move.

160 working days from 12th September yep. Not sure if the process is paused for any back and forth but all is very much on track for FDA news soon/H1.

Agree. All time lows here, one of the only AIM mining favs that is at the moment. Funded, with drilling about to commence.. a cracking time to buy

holding alone worth more than current Cap!

Majors in strong positions aren't afraid by the current OP dip! You have been implying for quite some time no one will get involved in assets when OP is low...

Im not actually sure why you still hold this? You seem to just ***** constantly... surely sell and move on?

As I was saying the other day, look at Tullows news today...

ADDYI by Sprout Pharma was the first FDA approved therapy in August 2015. Company was then soon after sold for $1bn by Cindy Eckert. This is tablet form with side affects such as depression, high blood pressure & takes 8 weeks to establish efficacy

VYLEESI by AMAG Pharma became the 2nd FDA approved in June 2019, this was acquired earlier for $440m (Has to be injected in to thigh 45mins before sex, side affects include headaches, vomiting)

Now then look at OVBs drug BP101 "The observed efficacy and safety profile of Ivix’ drug candidate suggests it is capable of becoming a market leader in this therapeutic area." Is a nasal spray with very limited side affects compared to the above competitors.

Upcoming News:

News due this next 2-6 weeks on filing for the western/US markets worth $2.25billion.

News also due on FDA approval for Russian marketing with sales then expected end of this year in a market worth $300million

lets face it the coivd-19 ramps have a shelf life now, the sentiment there will evaporate at the click of a finger when lockdowns start ending. Then Sex will be the big seller ;) haha

Biggest no brainer Pharma play on AIM for me this given how advanced their drug is and POLYshares/cash worth more than current MCap. No debt and directors have 50% skin in the game..

due soon I think. Nice catalyst here.

lots of newsflow due here, can see quite magnificent returns from this level in due course

Heavy volume going through here the last few days but by my calculations the company need to raise fairly imminently given £8m/year net cash burn and the £3.2m end of year cash balance.

Anyone have any clues as to how this is to be funded?

lets hope the rumours are true

encouraging hole 5 results will certainly help JV negotiations too.. sulphides is what the majors in the data room want

"theres a sell so someone doesn't agree" Do you understand what a market is? LOL

Director buys landed yesterday.

Given the director buys today and the language used in the previous RNS updates id say its looking very encouraging.

This oil price dip isn't going to last a long time, the lower the price goes and the longer it stays there then the bigger the rise as US shale goes bust and demand resumes as lockdowns end